AR012244A1 - Compuestos derivados de la 9-oxima eritomicina, composicion farmaceutica que los contiene, procedimiento para el tratamiento de una infeccion bacterianao protozoaria, procedimiento para su preparacion. - Google Patents
Compuestos derivados de la 9-oxima eritomicina, composicion farmaceutica que los contiene, procedimiento para el tratamiento de una infeccion bacterianao protozoaria, procedimiento para su preparacion.Info
- Publication number
- AR012244A1 AR012244A1 ARP980102703A ARP980102703A AR012244A1 AR 012244 A1 AR012244 A1 AR 012244A1 AR P980102703 A ARP980102703 A AR P980102703A AR P980102703 A ARP980102703 A AR P980102703A AR 012244 A1 AR012244 A1 AR 012244A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- procedure
- formula
- preparation
- integer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Abstract
Se describen los compuestos de formula I y a las sales Farmacéuticamente aceptables de los mismos, en la que R1, R2, R6 y X son lo definido en lapresente. También se describen composiciones farmacéuticas que contienen los compuestos de formulaI en el tratamiento de las infecciones bacterianas yprotozoarias y a procedimientos para la preparacion de dichos compuestos de formula I, donde en la que en dicho anillo de formula XVI, r y p son cada unode ellos independientemente un numero enntero de 1 a 3, q es 0 o 1 y X1 es -CH2- , O, S, -C(S)-, -SO2-, -CH=CH-, -CH(OH)CH(OH)-, o -NH-; y donde las partes(CH2), y (CH2)p de dicho anillo de formula XVI están opcionalmente sustituidas con 1 a 4 sustituyentes y el átomo de nitrogeno cuandoX1es -NH-estáopcionalmente sustituido con 1 sustituyente, estando dichos sustituyentes opcionales independientemente seleccionados entre el grupo constituido por-C(O)O(alquilo C1-C10), alcoxi C1-C10, alcanoílo C1-C10, halogeno, nitro, ciian o, heterociclilo de 5-10 elementos, alquilo C1-C10, -NR7R8, arilo C6-C10,-s(O)n (alquilo C1-C10) donde n es un numero entero de o a 2, y -SO2NR7R8; R1 es H o alquilo C1-C10, donde de 1 a 3 carbonos de dicho alquilo estánopcionalmente remplazadosporun heteroátomo seleccionado entre O, S y N, estando dicho alquilo opcionalmente sustituido con 1 a 3 sustituyentesseleccionados independientemente entre el grupo conastituido por -C(O)O(alquilo C1-C10), alcoxi C1-C10, alcanoílo C1-C10, aloggeno , nitro, ciano, heterociclilode 5-10 elementos, alquilo C1-C10, -NR7R8, arilo C6-C10, -S(O)n(alquilo C1-C10) donde n es un numero entero de 0 a 2 y -SO2NR7R8; R2 es (i) H, R4, -C(O)R4,-C(O)OR4 o -(CR7R8)mR3 cuando X es -NR7-, o (ii) H, R4, o -(CR7R8)mR3 cuando X es -CR7R8-, donde para ambos (i) y (ii) m es un numero entero de 0a 6 y tanto
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4934997P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012244A1 true AR012244A1 (es) | 2000-09-27 |
Family
ID=21959341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102703A AR012244A1 (es) | 1997-06-11 | 1998-06-09 | Compuestos derivados de la 9-oxima eritomicina, composicion farmaceutica que los contiene, procedimiento para el tratamiento de una infeccion bacterianao protozoaria, procedimiento para su preparacion. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0988308A1 (es) |
| JP (1) | JP2000513026A (es) |
| KR (1) | KR20010013660A (es) |
| CN (1) | CN1259135A (es) |
| AP (1) | AP9801253A0 (es) |
| AR (1) | AR012244A1 (es) |
| AU (1) | AU7226798A (es) |
| BG (1) | BG103947A (es) |
| BR (1) | BR9810021A (es) |
| CA (1) | CA2293335A1 (es) |
| CO (1) | CO4940506A1 (es) |
| CZ (1) | CZ9904388A3 (es) |
| EA (1) | EA199901016A1 (es) |
| GT (1) | GT199800074A (es) |
| HN (1) | HN1998000073A (es) |
| HR (1) | HRP980316A2 (es) |
| HU (1) | HUP0002252A3 (es) |
| ID (1) | ID24529A (es) |
| IL (1) | IL132767A0 (es) |
| IS (1) | IS5251A (es) |
| MA (1) | MA26505A1 (es) |
| NO (1) | NO996108L (es) |
| OA (1) | OA11225A (es) |
| PA (1) | PA8451801A1 (es) |
| PE (1) | PE79899A1 (es) |
| PL (1) | PL337606A1 (es) |
| TN (1) | TNSN98083A1 (es) |
| TR (1) | TR199902995T2 (es) |
| TW (1) | TW448174B (es) |
| WO (1) | WO1998056800A1 (es) |
| ZA (1) | ZA985018B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000159A (es) * | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
| ATE298761T1 (de) | 1998-09-22 | 2005-07-15 | Pfizer Prod Inc | Carbamat- und carbazatketolidantibiotika |
| FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
| US6258785B1 (en) | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
| EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
| US6284732B1 (en) * | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| ATE340183T1 (de) * | 1999-04-16 | 2006-10-15 | Kosan Biosciences Inc | Antiinfektiöse makrolidderivate |
| HUP0201516A3 (en) | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| WO2000075156A1 (en) * | 1999-06-07 | 2000-12-14 | Abbott Laboratories | 6-o-carbamate ketolide derivatives |
| ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
| EP1439186A3 (en) * | 1999-12-29 | 2004-11-03 | Pfizer Products Inc. | Intermediates for novel antibacterial and prokinetic macrolides |
| EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
| US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| US6403776B1 (en) | 2000-07-05 | 2002-06-11 | Pfizer Inc. | Synthesis of carbamate ketolide antibiotics |
| WO2003090761A1 (en) * | 2002-04-25 | 2003-11-06 | Abbott Laboratories | 9-oxime macrolide antibacterials |
| US7091196B2 (en) | 2002-09-26 | 2006-08-15 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using same |
| EP1638549A4 (en) * | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| EP1723159B1 (en) | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| US8796232B2 (en) | 2008-10-24 | 2014-08-05 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| AU2010292010B2 (en) | 2009-09-10 | 2016-01-07 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| CN102146085B (zh) * | 2010-02-09 | 2014-03-26 | 北京理工大学 | 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物 |
| CN103080122A (zh) | 2010-03-22 | 2013-05-01 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
| US9051346B2 (en) | 2010-05-20 | 2015-06-09 | Cempra Pharmaceuticals, Inc. | Process for preparing triazole-containing ketolide antibiotics |
| JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
| CN104470527B (zh) | 2012-03-27 | 2019-05-28 | 森普拉制药公司 | 用于施用大环内酯抗生素的肠胃外制剂 |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| US9751908B2 (en) | 2013-03-15 | 2017-09-05 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
1998
- 1998-05-15 EA EA199901016A patent/EA199901016A1/ru unknown
- 1998-05-15 IL IL13276798A patent/IL132767A0/xx unknown
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/hu unknown
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/cs unknown
- 1998-05-15 PL PL98337606A patent/PL337606A1/xx unknown
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/pt not_active IP Right Cessation
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/xx unknown
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/ko not_active Application Discontinuation
- 1998-05-15 ID IDW991570A patent/ID24529A/id unknown
- 1998-05-15 JP JP11501928A patent/JP2000513026A/ja active Pending
- 1998-05-15 CN CN98805848A patent/CN1259135A/zh active Pending
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Application Discontinuation
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/es unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/es unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/es unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/es not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/zh active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/es unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/fr unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/xx unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/fr unknown
- 1998-06-11 CO CO98033538A patent/CO4940506A1/es unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/hr not_active Application Discontinuation
-
1999
- 1999-11-16 IS IS5251A patent/IS5251A/is unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-03 BG BG103947A patent/BG103947A/xx unknown
- 1999-12-10 NO NO996108A patent/NO996108L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW448174B (en) | 2001-08-01 |
| KR20010013660A (ko) | 2001-02-26 |
| HN1998000073A (es) | 1999-01-08 |
| BG103947A (en) | 2000-07-31 |
| TNSN98083A1 (fr) | 2005-03-15 |
| BR9810021A (pt) | 2000-09-19 |
| NO996108L (no) | 2000-02-10 |
| PE79899A1 (es) | 1999-08-25 |
| AP9801253A0 (en) | 1999-12-04 |
| HUP0002252A3 (en) | 2002-01-28 |
| NO996108D0 (no) | 1999-12-10 |
| CA2293335A1 (en) | 1998-12-17 |
| CZ9904388A3 (cs) | 2002-10-16 |
| GT199800074A (es) | 1999-11-27 |
| EA199901016A1 (ru) | 2000-06-26 |
| ID24529A (id) | 2000-07-20 |
| IS5251A (is) | 1999-11-16 |
| EP0988308A1 (en) | 2000-03-29 |
| AU7226798A (en) | 1998-12-30 |
| HRP980316A2 (en) | 1999-04-30 |
| TR199902995T2 (xx) | 2000-02-21 |
| PA8451801A1 (es) | 2000-05-24 |
| PL337606A1 (en) | 2000-08-28 |
| HUP0002252A2 (hu) | 2000-12-28 |
| ZA985018B (en) | 1999-12-10 |
| IL132767A0 (en) | 2001-03-19 |
| OA11225A (en) | 2003-07-17 |
| JP2000513026A (ja) | 2000-10-03 |
| WO1998056800A1 (en) | 1998-12-17 |
| CO4940506A1 (es) | 2000-07-24 |
| MA26505A1 (fr) | 2004-12-20 |
| CN1259135A (zh) | 2000-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012244A1 (es) | Compuestos derivados de la 9-oxima eritomicina, composicion farmaceutica que los contiene, procedimiento para el tratamiento de una infeccion bacterianao protozoaria, procedimiento para su preparacion. | |
| AR007440A1 (es) | Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos. | |
| ES2173074T3 (es) | Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico. | |
| PT98545A (pt) | Processo para a preparacao de novos conjugados de antraciclinas utilizados como ligantes de agentes bioactivos | |
| IL69912A (en) | Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents | |
| ES8201143A1 (es) | Procedimiento para la preparacion de 2-azidometil-5-fenil-1h-2,3-dihidro-1,4-benzodiazepinas | |
| SE8603099L (sv) | Distamycinderivat och forfarande for deras framstellning | |
| MX16728A (es) | Derivados de piperidina 1-ariletil-3-substituidos y procedimiento para su preparacion | |
| ES2182114T3 (es) | Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano. | |
| PT81794B (pt) | Processo de preparacao de novos derivados da pristinamicina iib e das suas composicoes farmaceuticas | |
| ES2046671T3 (es) | Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas. | |
| AR018016A1 (es) | Compuestos derivados de eritrocina triciclico, composiciones farmaceutica, uso de los compuestos para prepararlas y procedimiento de preparacion | |
| DK0533827T3 (da) | Oxazolderivater, deres fremstilling og farmaceutiske præparater deraf | |
| DK624989A (da) | Makrolidforbindelser | |
| CA2146646A1 (en) | Benzopyranones, method of preparing them and their use | |
| PT89064A (pt) | Processo para a preparacao de compostos piperidinil-1,4-dissubstituidos com accao analgesica e miorrelaxante | |
| ES2068813T3 (es) | Derivados cefem de tiadiazolilacetamida. | |
| ES447751A1 (es) | Procedimiento para preparar derivados de imidazolilquinazo- lina. | |
| IL91541A0 (en) | Aryloxy-,arylthio-,heteroaryloxy-,and heteroarylthioalkenylene derivatives of amines,their preparation and pharmaceutical compositions containing them | |
| ES2038674T3 (es) | Procedimiento para la preparacion de una composicion de peroxido organico liquida. | |
| ES2161892T3 (es) | Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1. | |
| ES2053544T3 (es) | Un procedimiento para la preparacion de nuevos derivados de indol tetraciclicos. | |
| IL70630A (en) | Triazolopyridoquinazolinones,analogs thereof,their preparation and pharmaceutical compositions containing them | |
| SE8601013L (sv) | Tricykliska dibensokondenserade derivat och forfarande for deras framstellning | |
| ES2060095T3 (es) | Nuevas imidazobenzodiazepinas y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que los contienen. |